成人疫苗市场报告：2030 年趋势、预测与竞争分析

成人疫苗趋势和预测

至2030年，全球成人疫苗市场预计将达到244亿美元，2024年至2030年的复合年增长率为6.1%。该市场的主要驱动因素是传染病数量的增加以及政府为提高民众对疫苗接种重要性的认识而采取的支持措施。全球成人疫苗市场的未来看起来充满希望，为私人医疗保健公司和公立医院市场带来了机会。

成人疫苗市场洞察

Lucintel 预测，由于多效价疫苗在预防细菌和病毒性疾病方面的广泛应用，预计在预测期内将出现高速增长。

在这个市场中，私人医疗保健公司预计将在预测期内实现高速成长。

由于政府对免疫计划的大力支持以及该地区强大的医疗基础设施的存在，预计北美在预测期内将出现最高的增长。

市场规模/估计：以金额估计成人疫苗的市场规模（十亿美元）。

趋势和预测分析：各个细分市场和地区的市场趋势（2018-2023）和预测（2024-2030）。

細項分析：按技术、疫苗类型、最终用途和地区分類的成人疫苗市场规模（金额（十亿美元））。

区域分析：北美、欧洲、亚太地区以及世界其他地区、中东和非洲成人疫苗市场细分。

成长机会：依成人疫苗市场的技术、疫苗类型、最终用途和地区进行成长机会分析。

策略分析：成人疫苗市场併购、新产品开发、竞争形势等。

基于波特五力模型的产业竞争实力分析。

本报告回答了 11 个关键问题：

• Q.1. 细分市场中最有前途和高成长的机会是什么？
• Q.2.哪个细分市场将以更快的速度成长？为什么？
• Q.3.您认为哪些地区未来会出现更快的成长？为什么？
• Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
• Q.5. 这个市场的商业风险和竞争威胁是什么？
• Q.6.这个市场有哪些新趋势？为什么？
• Q.7.市场客户需求有何改变？
• Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
• Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
• Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
• Q.11.过去五年发生了哪些併购事件，对产业产生了哪些影响？

目录

第一章执行摘要

第二章全球成人疫苗市场：市场动态

• 简介、背景、分类
• 供应链
• 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

• 宏观经济趋势（2018-2023）与预测（2024-2030）
• 全球成人疫苗市场趋势（2018-2023）与预测（2024-2030）
• 按技术分類的全球成人疫苗市场
  • 原始弱化
  • 失活
  • 次单元
  • 类毒素
  • 组合型
  • 其他的
• 按疫苗类型分類的全球成人疫苗市场
  • 单价
  • 多效价的
• 全球成人疫苗市场（依最终用途）
  • 私人医疗公司
  • 公立医院

第四章 2018-2030年区域市场趋势及预测分析

• 全球成人疫苗市场区域分布
• 北美成人疫苗市场
• 欧洲成人疫苗市场
• 亚太地区成人疫苗市场
• 其他地区成人疫苗市场

第五章竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球成人疫苗市场成长机会（按技术）
  • 按疫苗类型分類的全球成人疫苗市场成长机会
  • 全球成人疫苗市场成长机会（依最终用途）
  • 全球成人疫苗市场成长机会（按地区）
• 全球成人疫苗市场的新趋势
• 战略分析
  • 新产品开发
  • 全球成人疫苗市场产能扩张
  • 全球成人疫苗市场的合併、收购与合资企业
  • 认证和许可

第七章主要企业概况

• Glaxosmithkline
• Merck & CO
• Sanofi
• Johnson & Johnson
• Serum institute India
• AstraZeneca
• Novartis

Adult Vaccine Trends and Forecast

The future of the global adult vaccine market looks promising with opportunities in the private healthcare firm and government hospital markets. The global adult vaccine market is expected to reach an estimated $24.4 billion by 2030 with a CAGR of 6.1% from 2024 to 2030. The major drivers for this market are growing cases of contagious diseases and supportive government initiatives to spread awareness about the importance of vaccination among population.

A more than 150-page report is developed to help in your business decisions.

Adult Vaccine by Segment

The study includes a forecast for the global adult vaccine by technology, vaccine type, end use, and region.

Adult Vaccine Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Live Attenuated
• Inactivated
• Subunit
• Toxoid
• Conjugate
• Others

Adult Vaccine Market by Vaccine Type [Shipment Analysis by Value from 2018 to 2030]:

• Monovalent
• Multivalent

Adult Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Private Healthcare Firms
• Government Hospitals

Adult Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Adult Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies adult vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the adult vaccine companies profiled in this report include-

• Glaxosmithkline
• Merck & Co
• Sanofi
• Johnson & Johnson
• Serum Institute India
• Astrazeneca
• Novartis

Adult Vaccine Market Insights

Lucintel forecasts that multivalent is expected to witness higher growth over the forecast period due to its broader application to protect against bacterial and viral illnesses.

Within this market, private healthcare firm is expected to witness higher growth over the forecast period.

North America is expected to witness highest growth over the forecast period due to presence of strong government support for immunization programs and existence of robust healthcare infrastructure in the region.

Features of the Global Adult Vaccine Market

Market Size Estimates: Adult vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Adult vaccine market size by technology, vaccine type, end use, and region in terms of value ($B).

Regional Analysis: Adult vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technologies, vaccine types, end uses, and regions for the adult vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the adult vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the adult vaccine market size?

Answer: The global adult vaccine market is expected to reach an estimated $24.4 billion by 2030.

Q.2 What is the growth forecast for adult vaccine market?

Answer: The global adult vaccine market is expected to grow with a CAGR of 6.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the adult vaccine market?

Answer: The major drivers for this market are growing cases of contagious diseases and supportive government initiatives to spread awareness about the importance of vaccination among population.

Q4. What are the major segments for adult vaccine market?

Answer: The future of the adult vaccine market looks promising with opportunities in the private healthcare firm and government hospital markets.

Q5. Who are the key adult vaccine market companies?

Answer: Some of the key adult vaccine companies are as follows:

• Glaxosmithkline
• Merck & Co
• Sanofi
• Johnson & Johnson
• Serum Institute India
• Astrazeneca
• Novartis

Q6. Which adult vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that multivalent is expected to witness higher growth over the forecast period due to its broader application to protect against bacterial and viral illnesses.

Q7. In adult vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to presence of strong government support for immunization programs and existence of robust healthcare infrastructure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the adult vaccine market by technology (live attenuated, inactivated, subunit, toxoid, conjugate , and others), vaccine type (monovalent and multivalent), end use (private healthcare firms and government hospitals), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Adult Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Adult Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Adult Vaccine Market by Technology
  • 3.3.1: Live Attenuated
  • 3.3.2: Inactivated
  • 3.3.3: Subunit
  • 3.3.4: Toxoid
  • 3.3.5: Conjugate
  • 3.3.6: Others
• 3.4: Global Adult Vaccine Market by Vaccine Type
  • 3.4.1: Monovalent
  • 3.4.2: Multivalent
• 3.5: Global Adult Vaccine Market by End Use
  • 3.5.1: Private Healthcare Firms
  • 3.5.2: Government Hospitals

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Adult Vaccine Market by Region
• 4.2: North American Adult Vaccine Market
  • 4.2.1: North American Adult Vaccine Market by Vaccine Type: Monovalent and Multivalent
  • 4.2.2: North American Adult Vaccine Market by End Use: Private Healthcare Firms and Government Hospitals
• 4.3: European Adult Vaccine Market
  • 4.3.1: European Adult Vaccine Market by Vaccine Type: Monovalent and Multivalent
  • 4.3.2: European Adult Vaccine Market by End Use: Private Healthcare Firms and Government Hospitals
• 4.4: APAC Adult Vaccine Market
  • 4.4.1: APAC Adult Vaccine Market by Vaccine Type: Monovalent and Multivalent
  • 4.4.2: APAC Adult Vaccine Market by End Use: Private Healthcare Firms and Government Hospitals
• 4.5: ROW Adult Vaccine Market
  • 4.5.1: ROW Adult Vaccine Market by Vaccine Type: Monovalent and Multivalent
  • 4.5.2: ROW Adult Vaccine Market by End Use: Private Healthcare Firms and Government Hospitals

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Adult Vaccine Market by Technology
  • 6.1.2: Growth Opportunities for the Global Adult Vaccine Market by Vaccine Type
  • 6.1.3: Growth Opportunities for the Global Adult Vaccine Market by End Use
  • 6.1.4: Growth Opportunities for the Global Adult Vaccine Market by Region
• 6.2: Emerging Trends in the Global Adult Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Adult Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Adult Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Glaxosmithkline
• 7.2: Merck & CO
• 7.3: Sanofi
• 7.4: Johnson & Johnson
• 7.5: Serum institute India
• 7.6: AstraZeneca
• 7.7: Novartis